(IBHE) iShares iBonds 2025 Term - Ratings and Ratios
Exchange: BATS • Country: USA • Currency: USD • Type: Etf • ISIN: US46435U1685 • Target Maturity
IBHE: High Yield Bonds, Corporate Bonds, Investment Grade Bonds, Fixed Income Securities
The iShares iBonds 2025 Term High Yield and Income ETF (IBHE) is an exchange-traded fund that focuses on investing in a portfolio of high-yield corporate bonds with maturities between January 1, 2025, and December 15, 2025. The funds investment strategy is designed to track the performance of its underlying index, which comprises U.S. dollar-denominated, taxable, fixed-rate corporate bonds rated BBB or equivalent.
By investing at least 80% of its assets in the component securities of the underlying index and at least 90% in fixed-income securities of similar types, the fund aims to provide investors with a targeted maturity date and a steady income stream. This makes IBHE an attractive option for investors seeking to manage their fixed-income exposure and cash flows around the specified maturity period.
Analyzing the technical data, we observe that the ETFs price is currently at $23.16, slightly above its 20-day and 50-day simple moving averages (SMA) of $23.11 and $23.05, respectively. The 200-day SMA stands at $22.65, indicating a longer-term uptrend. The Average True Range (ATR) is $0.06, or 0.27%, suggesting relatively low volatility. Given the proximity to its 52-week high of $23.18 and the overall trend, its likely that IBHE will continue to trade within a narrow range as it approaches maturity.
Considering the fundamental data, the funds Assets Under Management (AUM) stand at $577.67 million. This size is substantial enough to provide liquidity but not so large as to make significant redemptions problematic. The high-yield nature of the bonds in the portfolio means that the fund is exposed to credit risk, but the diversified nature of the index and the targeted maturity should help mitigate some of this risk.
Forecasting the ETFs performance based on the available data, we can expect IBHE to continue to trade near its current levels as it approaches maturity in 2025. The technical indicators suggest a stable trend, and the fundamental data indicate a manageable risk profile. As the bonds in the portfolio mature, the fund is likely to return capital to investors, potentially leading to a gradual decrease in AUM and a stable or slightly decreasing NAV as maturity approaches. Investors should monitor credit conditions and interest rate changes, as these could impact the ETFs performance. By the end of 2025, we can expect the fund to have largely returned capital to investors, making it a good option for those with a defined investment horizon.
Additional Sources for IBHE ETF
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
IBHE ETF Overview
Market Cap in USD | 578m |
Category | Target Maturity |
TER | 0.35% |
IPO / Inception | 2019-05-07 |
IBHE ETF Ratings
Growth Rating | 74.2 |
Fundamental | - |
Dividend Rating | 69.1 |
Rel. Strength | -4.22 |
Analysts | - |
Fair Price Momentum | 24.00 USD |
Fair Price DCF | - |
IBHE Dividends
Dividend Yield 12m | 5.98% |
Yield on Cost 5y | 8.18% |
Annual Growth 5y | 2.32% |
Payout Consistency | 96.0% |
IBHE Growth Ratios
Growth Correlation 3m | 88.3% |
Growth Correlation 12m | 99.6% |
Growth Correlation 5y | 86.3% |
CAGR 5y | 6.75% |
CAGR/Max DD 5y | 0.79 |
Sharpe Ratio 12m | 2.08 |
Alpha | 1.40 |
Beta | 0.059 |
Volatility | 2.46% |
Current Volume | 122.5k |
Average Volume 20d | 132.9k |
As of May 09, 2025, the stock is trading at USD 23.17 with a total of 122,530 shares traded.
Over the past week, the price has changed by +0.04%, over one month by +0.66%, over three months by +1.18% and over the past year by +5.98%.
Yes. Based on ValueRay Analyses, iShares iBonds 2025 Term (BATS:IBHE) is currently (May 2025) a good stock to buy. It has a ValueRay Growth Rating of 74.23 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of IBHE as of May 2025 is 24.00. This means that IBHE is currently overvalued and has a potential downside of 3.58%.
iShares iBonds 2025 Term has no consensus analysts rating.
According to ValueRays Forecast Model, IBHE iShares iBonds 2025 Term will be worth about 25.9 in May 2026. The stock is currently trading at 23.17. This means that the stock has a potential upside of +11.87%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 25.9 | 11.9% |